AAAhmet Aydin

Ahmet Aydin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ahmet Aydin has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • M1077 Effectiveness of Modified Sequential Treatment with Levofloxacin in a Country with Low Helicobacter pylori Eradication Rates

    by Ahmet Aydin, Nevin Oruc, Ilker Turan, Omer Ozutemiz, Muge Tuncyurek, Ahmet Musoglu

  • Üst gastrointestinal sistem lipomları: 33 olgunun irdelenmesi

    by Ahmet Aydin, Fatih Teki̇n, Murat Akyildiz, Ömer Özütemi̇z

    Giriş ve Amaç: Bu çalışmanın amacı, kliniğimizde lipom tanısı alan olgularımızın özelliklerini değerlendirmektir. Gereç ve Yöntem: Kliniğimizde Temmuz 2000-Şubat 2009 tarihleri arasında endoskopik ultrasonografi ile lipom tanısı alan 33 olgunun dosyaları retrospektif olarak irdelenmiştir. Bulgular: Onaltısı erkek (%48,5), 17'si (%51,5) kadın olan olguların yaş ortalaması 54 (33-85) idi. En sık endoskopi endikasyonu dispepsi idi. Tüm hastalar endoskopik ultrasonografideki tipik özellikler ile lipom tanısı aldı. Lezyonlar en sık olarak antrumda saptandı. Sonuç: Lipomların tanısında, tanı koydurucu tipik bulguların varlığı nedeniyle endoskopik ultrasonografi ilk tercih edilmesi gereken tanı yöntemidir.

    • 1 March 2008
      • Vol. 19  (1) , 73-4

    Granular cell tumor of colon.

    by Banu Sarsik, Başak Doğanavşargil, Ebru Emel Ozkök, Ahmet Aydin, Müge Tunçyürek


    • 1 December 2005
      • Vol. 16  (4) , 203-6

    The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.

    by Ahmet Aydin, Göktuğ F Onder, Ulus S Akarca, Fatih Tekin, Müge Tunçyürek, Ahmet Musoğlu

    Recent studies in Turkey have documented the noticeably low success rates of H. pylori eradication. It has become more important to identify the highly successful therapy regimens since clarithromycin resistance, one of the most important factors affecting the success rate of eradication therapies, continues to increase. The aim of this study was to assess the efficacy of two-week therapy with ranitidine bismuth citrate (RBC), amoxicillin (A), and clarithromycin (C) on H. pylori eradication, and the role of C resistance in eradication. The study included 45 dyspeptic patients with H. pylori diagnosed by urease test and histopathological examination. C resistance was studied by real-time PCR method on antral biopsy specimens. All patients were treated with a two-week therapy consisting of RBC: 2x400 mg, A: 2x1000 mg, and C: 2x500 mg, daily. Endoscopy was repeated at least one month after the end of the treatment. Presence of H. pylori was investigated by urease test and histopathological examination on antrum and corpus biopsies. Eradication was considered when both tests were negative for H. pylori in all specimens. Two cases were lost to follow-up. The average age of the remaining 43 patients (22 males, 21 females) was 46.3+/-11.5 years. Mild side effects were encountered in 20 (46.5%) patients. Eradication was achieved in 35 (81.4%) patients. C resistance was studied in 26 patients and was detected in 10 (38.5%) of them. H. pylori eradication rate was 81.3% in C-sensitive (13/16) and 80% in C-resistant patients (8/10) (p>0.05). A two-week regimen of RBC-A-C is very effective for H. pylori eradication even in C-resistant patients. These results suggest that RBC-A-C combination should be preferred for H. pylori eradication in Turkey.


    • 1 December 2004
      • Vol. 15  (4) , 233-7

    Value of endoscopic ultrasonography for upper gastrointestinal stromal tumors: a single center experience.

    by Ahmet Aydin, Fatih Tekin, Fulya Günşar, Adem Güler, Müge Tunçyürek, Tankut Ilter

    Gastrointestinal stromal tumors are the rarely seen tumors of the gastrointestinal tract. The aim of the present study was to review the patients diagnosed as upper gastrointestinal stromal tumor by endoscopic ultrasonography. Twenty-five patients diagnosed as upper gastrointestinal stromal tumor, between 1999 and 2004, were reviewed retrospectively. The reason for performing upper gastrointestinal system endoscopy was nonspecific upper gastrointestinal system symptoms in most (76%) of the patients. The other causes were upper gastrointestinal bleeding and dysphagia in 16% and 8% of the cases, respectively. Lesions were located in the stomach in 17 (68%), in the esophagus in six (24%), and in the duodenum in two (8%) patients. Endoscopic ultrasonographic evaluation revealed that all of the lesions arose from the muscularis propria. In 18 (72%) patients, tumors were less than 3 cm in diameter, homogeneous and hypoechoic in appearance with regular borders, concordant with benign tumor. In five (20%) patients, lesions had heterogeneous echoic appearance with anechoic spaces, two of which were larger than 3 cm and also showed irregular borders, suggesting malignancy. Surgical therapy was performed in five (20%) patients because of upper gastrointestinal bleeding or suspicion of malignancy by endoscopic ultrasonographic evaluation. Histopathological examination confirmed the diagnosis in all these patients. Endoscopic ultrasonographic evaluation is very useful in diagnosis and for choosing the therapeutic method for patients with upper gastrointestinal stromal tumor.